Published in Mol Vis on September 12, 2005
Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci U S A (2006) 4.66
The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties. Invest Ophthalmol Vis Sci (2011) 2.03
Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype. Cell Stem Cell (2009) 2.00
Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. Br J Cancer (2010) 1.85
High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells. Stem Cells (2009) 1.67
Human embryonic and neuronal stem cell markers in retinoblastoma. Mol Vis (2007) 1.66
The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype. Am J Pathol (2008) 1.49
Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med (2007) 1.48
Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters. Biochem Pharmacol (2012) 1.31
Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy. Cell Death Differ (2011) 1.30
Selection of tumorigenic melanoma cells using ALDH. J Invest Dermatol (2010) 1.27
Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies. Clin Pharmacol Ther (2007) 1.25
Human ABCG2: structure, function, and its role in multidrug resistance. Int J Biochem Mol Biol (2011) 1.21
hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. Br J Cancer (2010) 1.19
Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer. PLoS One (2012) 1.18
Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus. Clin Cancer Res (2008) 1.18
Persistence of side population cells with high drug efflux capacity in pancreatic cancer. World J Gastroenterol (2008) 1.18
Inconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastoma. J Histochem Cytochem (2011) 1.14
Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach. J Exp Clin Cancer Res (2013) 1.13
Targeting cancer stem cells: a new therapy to cure cancer patients. Am J Cancer Res (2012) 1.11
Advances in complex multiparameter flow cytometry technology: Applications in stem cell research. Cytometry B Clin Cytom (2009) 1.10
Stem cell markers: ABCG2 and MCM2 expression in retinoblastoma. Br J Ophthalmol (2006) 1.09
Lithium chloride regulates the proliferation of stem-like cells in retinoblastoma cell lines: a potential role for the canonical Wnt signaling pathway. Mol Vis (2010) 1.03
Deoxycholate promotes survival of breast cancer cells by reducing the level of pro-apoptotic ceramide. Breast Cancer Res (2008) 1.03
Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulations. Ann Transl Med (2014) 0.99
Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas. BMC Cancer (2009) 0.98
Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway. J Exp Clin Cancer Res (2011) 0.97
Tumor-associated retinal astrocytes promote retinoblastoma cell proliferation through production of IGFBP-5. Am J Pathol (2010) 0.92
Investigating molecular profiles of ovarian cancer: an update on cancer stem cells. J Cancer (2014) 0.90
Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies. Mol Aspects Med (2013) 0.85
EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell-mediated immunotherapy. Mol Vis (2012) 0.85
A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential. Br J Haematol (2012) 0.83
Vascular Recruitment of Human Retinoblastoma Cells by Multi-Cellular Adhesive Interactions with Circulating Leukocytes. Cell Mol Bioeng (2010) 0.83
Characterization and retinal neuron differentiation of WERI-Rb1 cancer stem cells. Mol Vis (2012) 0.82
Circulating cancer stem cells: the importance to select. Chin J Cancer Res (2015) 0.81
Side population cells isolated from KATO III human gastric cancer cell line have cancer stem cell-like characteristics. World J Gastroenterol (2012) 0.81
Regulation of mitotic cytoskeleton dynamics and cytokinesis by integrin-linked kinase in retinoblastoma cells. PLoS One (2014) 0.80
Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers. Panminerva Med (2008) 0.79
Retinoblastoma: Recent trends A mini review based on published literature. Oman J Ophthalmol (2011) 0.78
Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells. Clin Exp Metastasis (2016) 0.77
RB116: an RB1+ retinoblastoma cell line expressing primitive markers. Mol Vis (2012) 0.77
Differential expression of stem cell markers and vascular endothelial growth factor in human retinoblastoma tissue. Korean J Ophthalmol (2010) 0.77
Loukoumasomes Are Distinct Subcellular Structures from Rods and Rings and Are Structurally Associated with MAP2 and the Nuclear Envelope in Retinal Cells. PLoS One (2016) 0.77
Residual intraretinal retinoblastoma after chemoreduction failure. Arch Ophthalmol (2012) 0.76
Molecular pathology of retinoblastoma. Middle East Afr J Ophthalmol (2010) 0.75
Role of B lymphoma Mo-MLV insertion region 1 in the oncogenic behavior of retinoblastomas. Mol Vis (2013) 0.75
Silencing of ABCG2 by MicroRNA-3163 Inhibits Multidrug Resistance in Retinoblastoma Cancer Stem Cells. J Korean Med Sci (2016) 0.75
HER2/ERBB2 immunoreactivity in human retinoblastoma. Tumour Biol (2015) 0.75
Acute lymphoid leukemia cells with greater stem cell antigen-1 (Ly6a/Sca-1) expression exhibit higher levels of metalloproteinase activity and are more aggressive in vivo. PLoS One (2014) 0.75
Enhanced SOX2 expression in retinoblastoma tissues and peripheral blood is associated with the clinicopathological characteristics of the disease. Oncol Lett (2015) 0.75
Immunoreactivity of Pluripotent Markers SSEA-5 and L1CAM in Human Tumors, Teratomas, and Induced Pluripotent Stem Cells. J Biomark (2013) 0.75
Human embryonic and neuronal stem cell markers in retinoblastoma. Mol Vis (2007) 1.66
A homozygous missense mutation in the IRBP gene (RBP3) associated with autosomal recessive retinitis pigmentosa. Invest Ophthalmol Vis Sci (2008) 1.27
Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts. Exp Eye Res (2008) 1.09
Crystal structure of the functional unit of interphotoreceptor retinoid binding protein. Structure (2002) 1.07
NF-κB forms a complex with the chromatin remodeler BRG1 to regulate Schwann cell differentiation. J Neurosci (2013) 0.98
Neuronal gene expression and function in the growth-stimulated R28 retinal precursor cell line. Curr Eye Res (2004) 0.98
Systemic IGF-I treatment inhibits cell death in diabetic rat retina. J Diabetes Complications (2006) 0.97
Human corneal stem cells display functional neuronal properties. Mol Vis (2003) 0.96
Early onset sebaceous carcinoma. Diagn Pathol (2011) 0.94
Cone outer segment and Müller microvilli pericellular matrices provide binding domains for interphotoreceptor retinoid-binding protein (IRBP). Exp Eye Res (2013) 0.90
Reversible folding of human peripheral myelin protein 22, a tetraspan membrane protein. Biochemistry (2013) 0.89
Histogenesis of retinal dysplasia in trisomy 13. Diagn Pathol (2007) 0.88
Internalization of interphotoreceptor retinoid-binding protein by the Xenopus retinal pigment epithelium. J Comp Neurol (2003) 0.86
Carotenoids as possible interphotoreceptor retinoid-binding protein (IRBP) ligands: a surface plasmon resonance (SPR) based study. Arch Biochem Biophys (2013) 0.86
Nocardia keratitis after laser in situ keratomileusis: clinicopathologic correlation. J Cataract Refract Surg (2005) 0.84
Cone outer segment extracellular matrix as binding domain for interphotoreceptor retinoid-binding protein. J Comp Neurol (2012) 0.82
The interphotoreceptor retinoid-binding protein (IRBP) of the chicken (Gallus gallus domesticus). Mol Vis (2005) 0.81
Albumin is not present in the murine interphotoreceptor matrix, or in that of transgenic mice lacking IRBP. Mol Vis (2004) 0.77
High-throughput microtiter assay for Hoechst 33342 dye uptake. Cytotechnology (2004) 0.77
Purification of the full-length Xenopus interphotoreceptor retinoid binding protein and growth of diffraction-quality crystals. Mol Vis (2007) 0.77
Conformational Stability and Pathogenic Misfolding of the Integral Membrane Protein PMP22. J Am Chem Soc (2015) 0.76
Maspin increases extracellular plasminogen activator activity associated with corneal fibroblasts and myofibroblasts. Exp Eye Res (2011) 0.75
Withaferin A Regulates LRRK2 Levels by Interfering with the Hsp90- Cdc37 Chaperone Complex. Curr Aging Sci (2015) 0.75
A 47-year-old man with sudden onset of blindness, pleocytosis, and temporary hearing loss. Vogt-Koyanagi-Harada syndrome (Uveomeningoencephalitic syndrome). Arch Pathol Lab Med (2006) 0.75